transplant infection disease - Yahoo News Search Results
Appeal after Wolverhampton nurse dies of rare disease
Samantha Green, died aged 30, in October after developing Graft Versus Host Disease (GVHD) in her lungs. The mother-of-one from Oxley had battled and overcome leukaemia twice and received a bone marrow transplant from her sister Nicola Green, 28, on both occasions.
Double-lung transplant gives Beaufort woman new chance for life
Jessica Mattson, 36, of Beaufort, is enjoying a new lease on life after having successfully gone through a double-lung transplant as part of her ongoing battle with cystic fibrosis
- AbbVie Receives U.S. FDA Approval of VIEKIRA PAK™ (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) for ...
Resistance to anti-viral drug may be more likely in cystic fibrosis patients
Following lung transplantation, resistance to the anti-viral drug ganciclovir may be more likely in cystic fibrosis patients, scientists report. Ganciclovir is given to lung transplant patients to protect against a life-threatening virus that is common after transplantation, and reduces mortality due to the virus from 34 percent to between 3 and 6 percent. But between 5 percent and 10 percent of ...
After Lung Transplantation, Resistance to Anti-Viral Drug May be More Likely in Cystic Fibrosis Patients
Among lung transplant patients, those with cystic fibrosis may be more likely to develop resistance to the antiviral drug ganciclovir.
A fresh setback for efforts to cure HIV infection
Researchers are reporting another disappointment for efforts to cure infection with the AIDS virus. Six patients given blood-cell transplants similar to one that cured a man known as "the Berlin patient" ...
Rebiotix Announces First-Ever Randomized Study of a Microbiota-based Drug for Recurrent Clostridium difficile ...
First enrollment cements Rebiotix leadership in drive to commercialize next-generation fecal transplant product. (PRWeb December 16, 2014) Read the full story at http://www.prweb.com/releases/2014/12/prweb12394212.htm
Positive data from pivotal phase III study could improve standard of care for Hodgkin lymphoma patients
In a late-stage clinical trial, Hodgkin lymphoma patients who received brentuximab vedotin post-transplant lived longer without disease progression than patients who received only supportive care, researchers report.
Positive study data could improve standard of care for Hodgkin lymphoma patients
( Memorial Sloan-Kettering Cancer Center ) In a late-stage clinical trial, Hodgkin lymphoma patients who received brentuximab vedotin post-transplant lived longer without disease progression than patients who received only supportive care.
Transplant patients died after receiving kidneys with rare parasitic worm
Doctors not to blame for neglect as two men suffered ‘unintended consequences’ of operation, coroner rules Two transplant patients died from “unintended consequences of necessary medical intervention” after they were accidentally given kidneys with parasitic worms, a coroner has ruled. Darren Hughes, 42, from Bridgend, and Robert “Jim” Stuart, 67, from Cardiff, underwent the operation at the ...